Nippon Shinyaku

Last updated

Nippon Shinyaku
Company typePublic (K.K) [1] [2]
IndustryPharmaceuticals, Functional Foods [1] [2] [3]
FoundedOctober 1, 1919;106 years ago (1919-10-01) in Kyoto, Japan [2]
Headquarters
Kyoto [2][1][5] [1] [2] [4]
,
Japan [1] [2] [4]
Area served
Worldwide [1] [2] [3]
Key people
Toru Nakai (President), Shigenobu Maekawa (Chairman), Takashi Takaya (Director), Kazuchika Takagaki (Director, Head R&D) [2][6][7][8]
ProductsPrescription drugs, functional foods [1] [2]
Number of employees
2,243 [2] [4] [5]  (2025 [2] [5] )
Website www.nippon-shinyaku.co.jp/english/ [1] [2]

Nippon Shinyaku Co., Ltd. is a Japanese pharmaceutical company headquartered in Kyoto that develops, manufactures, and markets prescription drugs and functional foods. Founded in 1911, the company initially focused on herbal medicines before expanding into modern pharmaceuticals, with current therapeutic areas including urology, hematology, intractable and rare diseases, and gynecology. [6] Nippon Shinyaku is listed on the Tokyo Stock Exchange and has developed treatments such as viltolarsen for Duchenne muscular dystrophy. [7]

References

  1. 1 2 3 4 5 6 7 "Nippon Shinyaku Co Ltd (NPPNY) Company Profile". Stock Analysis. Retrieved 13 September 2025.
  2. 1 2 3 4 5 6 7 8 9 10 "Company Profile". Nippon Shinyaku. Retrieved 13 September 2025.
  3. 1 2 "Nippon Shinyaku Co., Ltd. Company Profile". MarketScreener. Retrieved 13 September 2025.
  4. 1 2 3 "Nippon Shinyaku Co Ltd Company Profile". Financial Times. Retrieved 13 September 2025.
  5. 1 2 "Nippon Shinyaku Co Ltd (4516.T) Employees". Stock Analysis. Retrieved 13 September 2025.
  6. ↑ Yamaura T (March 2011). "[History of the Nippon Shinyaku Institute for Botanical Research]". Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan (in Japanese). 131 (3): 395–400. doi:10.1248/yakushi.131.395. PMID   21372535.
  7. ↑ Dhillon S (July 2020). "Viltolarsen: First Approval". Drugs. 80 (10): 1027–1031. doi:10.1007/s40265-020-01339-3. PMID   32519222.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.